wavePod

AI-powered podcast summaries delivered to your inbox within minutes of release.

Product

How It Works
Browse Podcasts
Your Library

Company

About Wave
Privacy Policy
Terms of Service

Get Wave AI

Download App
WaveTube — YouTube Summaries
Contact

Wave AI Tools

AI Transcription App
Speech to Text App
Audio to Text Converter
Audio Transcription Software
AI Note Taking App
AI Note Taker
Meeting Notes App
Meeting Transcription App
AI Meeting Recording App
Voice Recorder App
Lecture Recording App
Call Recording App
Online Voice Recorder
Transcribe Video to Text
Audio Recorder App iPhone
Phone Call Recorder iPhone
Voice Memo App Android
Sales Call Recording Tool

© 2026 Wave. All rights reserved.

Back to This Week In Medicine

NEJM February 2026 Trastuzumab Deruxtecan in Residual HER2-Positive Early Breast Cancer - This Week In Medicine cover

NEJM February 2026 Trastuzumab Deruxtecan in Residual HER2-Positive Early Breast Cancer

This Week In Medicine

Thu Feb 26 2026

Get Free Podcast Summaries in Your Inbox

Subscribe to your favorite podcasts and get free AI summaries within minutes of release.

1

Pick Your Shows

Browse trending podcasts or search for your favorites

2

Subscribe Free

One click to follow any show — always free, no credit card

3

Get Instant Summaries

Free AI summaries delivered by email within minutes of release

Free forever · No credit card · Unsubscribe anytime

Loading summary...

Never miss an episode of This Week In Medicine. Subscribe for free →

No transcript available.

NEJM February 2026 Trastuzumab Deruxtecan in Residual HER2-Positive Early Breast Cancer - This Week In Medicine | Wave AI Podcast Notes